EAM Investors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

EAM Investors’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-132,144	Closed	-$3.39M	–	410
2021 Q2	$3.39M	Hold	132,144	–	–	0.52%	42
2021 Q1	$2.41M	Sell	132,144 -30,470	-19%	-$506K	0.36%	81
2020 Q4	$1.88M	Buy	+162,614	New	+$1.49M	0.31%	140
2020 Q1	–	Sell	-201,835	Closed	-$1.55M	–	298
2019 Q4	$1.55M	Buy	201,835 +90,627	+81%	+$529K	0.34%	137
2019 Q3	$589K	Buy	+111,208	New	+$690K	0.16%	225
2019 Q1	–	Sell	-353,982	Closed	-$1.45M	–	328
2018 Q4	$1.45M	Buy	353,982 +59,108	+20%	+$308K	0.39%	117
2018 Q3	$2.02M	Buy	+294,874	New	+$1.75M	0.3%	150

Other funds holding CDMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

EAM Investors's CDMO Position: Q3 2021 in Review

EAM Investors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2021, closing a stake of 132,144 shares — an estimated $3.39M sold.

EAM Investors first reported a position in CDMO in Q3 2018 and held it in 7 quarters. The position peaked at $3.39M in Q2 2021. 161 funds tracked by Wall St. Rank hold CDMO as of Q3 2021.

EAM Investors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
EAM Investors sold 132,144 Avid Bioservices, Inc. Common Stock shares in Q3 2021, an estimated $3.39M.
EAM Investors first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 7 quarters.
EAM Investors's Avid Bioservices, Inc. Common Stock position peaked at $3.39M in Q2 2021.
161 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2021.

Based on EAM Investors's 13F filing for Q3 2021, filed 12 Nov 2021.